The good and bad side of anti-cancer compounds

Compounds known as “HDAC inhibitors” exhibit cancer-killing activities in cultured cells. While they are currently being tested as anti-cancer agents in clinical trials, just how they execute their effects is unclear.

If you want to include this story in your blog, copy and paste this formatted text:

<p><a href="http://www.physorg.com/news127052335.html">The good and bad side of anti-cancer compounds</a></p> <p>Compounds known as “HDAC inhibitors” exhibit cancer-killing activities in cultured cells. While they are currently being tested as anti-cancer agents in clinical trials, just how they execute their effects is unclear.</p>